Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01185 (vasopressin)
 23,126 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The objective of the current study was to find a cost-effective way of correlating spot urine osmolalities, bladder capacity and age in patients with monosymptomatic nocturnal enuresis with response to treatment with desmopressin (Minirin, DDAVP). A total of 35 children fulfilled the entry criteria and were included in the study. Constipation was eliminated in these children by appropriate enema treatment and diet adjustment prior to enrollment. Urine samples were collected at home at times that would best reflect fluctuations in plasma vasopressin levels (08:00, 16:00 and 22:00) over three consecutive 24-hour periods. Maximal functional bladder capacity was determined from the largest voided volume. A 2-week dose-titration treatment period with intranasal desmopressin was then conducted. With doses of desmopressin being increased by 10 micrograms every 3 days. Response to desmopressin treatment was then assessed and factors that were observed to be markers of a favourable response were noted. Of the 35 children, 27 demonstrated a complete response to desmopressin treatment, at doses of 10-30 micrograms. Spot urine osmolalities were not predictive of the response to desmopressin (P > 0.1). In contrast, there was a significant correlation between a high maximum functional bladder capacity and response to desmopressin (P = 0.006). Age was also predictive of a good response to desmopressin treatment (P = 0.008).
 ...
PMID:Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis. 916 5

Home recordings were used to study the effect of alarm treatment, over a period of 6 weeks, in children with monosymptomatic nocturnal enuresis. Vasopressin day/night ratios were shown to be a good indicator of alarm treatment success. Serial measurement of plasma vasopressin levels is, however, unsuitable for use in the clinic, as extensive analyses would have to be performed to obtain the necessary results. Use of an alarm increased nocturnal bladder capacity, but had no effect on daytime bladder capacity, sleep patterns, vasopressin secretion, nocturnal urine output or pelvic floor activity. In addition, the results of the study suggest that an alarm treatment period of 2 months would lead to more successful results than the 6 weeks used in the study.
 ...
PMID:Alarm treatment: influence on functional bladder capacity. 916 10

Body fluid homeostasis is maintained by the kidney. Such an accurate control in achieved via the secretion of antidiuretic hormone (ADH), the secretion of which is regulated by hypothalamic osmoreceptors. Both urine flow rate and the excretion of most electrolytes have a diurnal rhythm; they increase during daytime and decrease during nighttime. Such a rhythm seems to be absent in some subjects who suffer from bedwetting because of relative polyuria. In these cases, the polyuria is associated with a decreased nocturnal secretion of ADH and the subsequent excretion of dilated urine. A deficit in the nocturnal secretion of ADH thus appears to explain the response to desmopressin of children with a polyuric form of enuresis.
 ...
PMID:[Endocrine theory of idiopathic nocturnal enuresis]. 918 Oct 1

Peculiarities of the excretion of ions (Na, K, Ca, Mg) and water were studied in healthy children and children with the nocturnal enuresis, aged 6-15 years. A greater diuresis in the enuretic children is due to an increased excretion of the osmotically active substances including Na and Mg; excretion of K and Ca does nor differ from the control. A new formula is proposed for the quantitative evaluation of the role of different substances in the osmolar clearance. A high correlation is found between the sodium and magnesium excretion and the osmotic free water reabsorption. A single intranasal administration of 1-deamino-8-D-arginine-vasopressin (DDAVP) to the children before their going to bed returned to the norm the sodium and magnesium excretion in the enuretic children. It is suggested that the defect peculiar to this particular pathology is associated with a decrease in the ion reabsorption in the thick ascending Henle loop. The normal level of the ion transport is restored after stimulation of V2-receptors by DDAVP. An explanation is suggested of the mechanism of the increase of diuresis with a simultaneous rise in the osmotically free water reabsorption in children with enuresis.
 ...
PMID:[A physiological analysis of kidney ion-regulating function in children with enuresis]. 918 48

Millions of children nationwide are affected by nocturnal enuresis. Despite the numbers of children affected, enuresis continues to be poorly understood is and often poorly managed. Because enuresis is a symptom and not a disease, it is difficult to discern a cause or an effective treatment. Although less than 5% of children with nocturnal enuresis have an organic basis for their wetting, the physical examination and history should carefully rule out any physical causes. Factors that have been observed to be associated with the occurrence of nocturnal enuresis include developmental delay, introduction of negative factors, heredity, small bladder capacity, and reduced nocturnal secretion of antidiuretic hormone. The cornerstone of therapy for all children with nocturnal enuresis should be behavioral management. Medical management should be initiated only after behavioral management has failed. No one therapy guarantees success, and multiple therapies may be attempted before dryness is obtained.
 ...
PMID:Nocturnal enuresis in children. 931 33

After allergic disorders, nocturnal enuresis is the most common chronic childhood condition. Recent research has yielded abundant new knowledge about the condition, especially about its aetiology and pathophysiology, and the psychological consequences. A hereditary background has been substantiated by the identification in genetic linkage studies of areas in chromosomes 12 and 13 that are manifestly associated with bedwetting, though genotype expression in the phenotype appears to be complex and heterogeneous. Pathophysiologically, findings in current intensive research suggest three interactive factors to be involved: (i) relative nocturnal polyuria, due to insufficient antidiuretic hormone release during sleep in pre-teenagers, and due to renal tubular dysfunction in adolescents and adults; (ii) reduced nocturnal bladder capacity, especially in the 33 per cent of cases which do not respond to desmopressin treatment; and (iii) the patient's inability to waken in response to signals from a full bladder. Recent findings have also confirmed previous reports that with very few exceptions bedwetting is not caused by psychological factors. On the contrary, the condition causes psychological problems manifested in reduced self-esteem, shame and guilt, though self-esteem is restored by successful treatment. Active treatment should be started as soon as the child is ready to receive it, the main options being an enuresis alarm, desmopressin, or a combination of the two. If reduced bladder capacity is suspected, treatment with a detrusor relaxant should be included.
 ...
PMID:[Nocturnal enuresis in children]. 946 1

More than 700 children aged between 5 and 15 years were treated at the University of Vienna Department of Urology during the last 10 years. The therapeutic approach was based on a complex diagnostic scheme to define the individual problem of each enuretic child. Generally speaking the enuresis problem turned out to be a symptom of delayed maturation of fine motor control [1] or sleep and hormone secretion rhythm during day and night hours. In a high percentage of enuretic children, no major physical problem or disease could be found, but the possibility of a physical problem, especially a neurourological problem, should not be ignored. Nonneurogenic discoordinated voiding in children can be treated by cognitive flow-triggered feedback training [2, 3] while overproduction of urine during sleep is reduced by antidiuretic hormone therapy with desmopressin (DDAVP; 1-deamino-8-D-arginine-vasopressin), a synthetic analogue of antidiuretic hormone.
 ...
PMID:Therapy concept in enuretic children. 959 39

Primary nocturnal enuresis sometimes presents significant psychosocial problems for children and their parents. Causative factors may include maturational delay, genetic influence, difficulties in waking and decreased nighttime secretion of antidiuretic hormone. Anatomic abnormalities are usually not found, and psychologic causes are unlikely. Evaluation of enuresis usually requires no more than a complete history, a focused physical examination, and urine specific gravity and dipstick tests. Nonpharmacologic treatments include motivational therapy, behavioral conditioning and bladder-training exercises. Pharmacologic therapy includes imipramine, anticholinergic medication and desmopressin. These drugs have been used with varying degrees of success.
 ...
PMID:Primary nocturnal enuresis: current. 1008 76

Nocturia is a common and troublesome symptom in otherwise healthy elderly men and women. Nocturnal polyuria (an excessive nighttime urine output) has been documented to be a common finding in healthy men with lower urinary tract symptoms. It is also a presenting feature of various medical conditions, such as renal failure, hypercalcemia and diabetes. Fluid balance therapy is an option in those whose nocturia is secondary to nocturnal polyuria. If a reduction in fluid intake fails to reduce nocturnal frequency a variety of drug treatments may be beneficial. Several studies have confirmed the efficacy of intranasal DDAVP, a synthetic analog of antidiuretic hormone, in both healthy patients and those with neuropathic bladders, although fluid overload and hyponatremia are potential side effects. Other drug treatments include early evening diuretics, such as frusemide or bumetanide. More recently imipramine has shown therapeutic benefit in young adults with enuresis, and might prove to be useful in the elderly with nocturnal polyuria.
 ...
PMID:Fluid balance therapy of nocturia in women. 1020 67

Enuresis is the result of multifactorial processes. Enuretic patients often exhibit an abnormal diurnal rhythm of plasma vasopressin in addition to high nocturnal urine production. Renal function is considered to be a core factor in influencing the volume of fluid delivered to the bladder. Animal studies have suggested that the amount of fluid delivered to the bladder is dependent upon the state of hydration and/or the amount of protein present in the animal's diet. The state of hydration, or diuresis, may also influence the permeability of the terminal collecting ducts to water and urea and the hydro-osmotic response of the kidney to desmopressin. Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.
 ...
PMID:Effects of water balance, diet and antidiuretic-hormone administration on the renal excretion of water. 1057 89


<< Previous 1 2 3 4 5 6 7 8 9 Next >>